Skip to main content

GOLDMAN SACHS GROUP INC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 886982 NEW YORK, NY

Position in RCKT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$6,161,594
+$2,874,150 QoQ
Shares Held
1,721,116
+83.8% QoQ
Ownership
1.58%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RCKT Over Time

Shares Held

Position Value (USD)

Derivatives in RCKT

reported options exposure · as of Mar 31, 2026
CallValue
$501,200
CallShares
140,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. RCKT ranks #168 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RCKT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $6,161,594 1,721,116
2026-03-31 $501,200 140,000
2025-12-31 $3,287,444 936,594
2025-09-30 $4,143,762 1,271,093
2025-06-30 $3,859,896 1,575,468
2025-03-31 $6,641,251 995,690
2024-12-31 $10,091,006 802,785
2024-09-30 $7,832,627 424,073
2024-06-30 $14,982,899 695,908
2024-03-31 $11,607,771 430,875
2023-12-31 $17,822,109 594,665
2023-09-30 $10,853,941 529,719
2023-06-30 $28,630,881 1,440,910
2023-03-31 $28,294,083 1,651,727
2022-12-31 $20,140,738 1,029,164
2022-09-30 $32,504,837 2,036,644
2022-06-30 $20,679,834 1,502,895
2022-03-31 $24,611,134 1,551,774
2021-12-31 $14,513,784 664,855
2021-09-30 $28,921,473 967,597
2021-06-30 $32,876,687 742,305
2021-03-31 $49,376,488 1,112,835
2020-12-31 $51,766,765 943,960
2020-09-30 $25,776,935 1,127,600
2020-06-30 $13,897,122 663,981
2020-03-31 $10,832,412 776,517